BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li S, Goins B, Hrycushko BA, Phillips WT, Bao A. Feasibility of eradication of breast cancer cells remaining in postlumpectomy cavity and draining lymph nodes following intracavitary injection of radioactive immunoliposomes. Mol Pharm 2012;9:2513-22. [PMID: 22894603 DOI: 10.1021/mp300132f] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Dmitrieva MV, Yarosh IV, Sanarova EV, Lantsova AV, Orlova OL. The Construction of Immunoliposomes (Review). Razrabotka i registraciâ lekarstvennyh sredstv 2022;11:97-112. [DOI: 10.33380/2305-2066-2022-11-3-97-112] [Reference Citation Analysis]
2 Veselov VV, Nosyrev AE, Jicsinszky L, Alyautdin RN, Cravotto G. Targeted Delivery Methods for Anticancer Drugs. Cancers (Basel) 2022;14:622. [PMID: 35158888 DOI: 10.3390/cancers14030622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Felici A, Di Mascolo D, Ferreira M, Lauciello S, Bono L, Armirotti A, Pitchaimani A, Palange AL, Decuzzi P. Vascular-confined multi-passage discoidal nanoconstructs for the low-dose docetaxel inhibition of triple-negative breast cancer growth. Nano Res 2022;15:482-91. [DOI: 10.1007/s12274-021-3507-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rosenkranz AA, Slastnikova TA. Epidermal Growth Factor Receptor: Key to Selective Intracellular Delivery. Biochemistry (Mosc) 2020;85:967-1092. [PMID: 33050847 DOI: 10.1134/S0006297920090011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
5 Gabizon AA, de Rosales RTM, La-Beck NM. Translational considerations in nanomedicine: The oncology perspective. Adv Drug Deliv Rev 2020;158:140-57. [PMID: 32526450 DOI: 10.1016/j.addr.2020.05.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
6 Akbarzadeh Khiavi M, Safary A, Barar J, Ajoolabady A, Somi MH, Omidi Y. Multifunctional nanomedicines for targeting epidermal growth factor receptor in colorectal cancer. Cell Mol Life Sci 2020;77:997-1019. [DOI: 10.1007/s00018-019-03305-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
7 Goins B, Bao A, Phillips WT. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy. Methods Mol Biol 2017;1522:155-78. [PMID: 27837538 DOI: 10.1007/978-1-4939-6591-5_13] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
8 Wali S, Gupta R, Yu JJ, Mfuh A, Gao X, Guentzel MN, Chambers JP, Abu Bakar S, Zhong G, Arulanandam BP. Guinea pig genital tract lipidome reveals in vivo and in vitro regulation of phosphatidylcholine 16:0/18:1 and contribution to Chlamydia trachomatis serovar D infectivity. Metabolomics 2016;12:74. [PMID: 27642272 DOI: 10.1007/s11306-016-0998-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
9 Alavizadeh SH, Soltani F, Ramezani M. Recent Advances in Immunoliposome-Based Cancer Therapy. Curr Pharmacol Rep 2016;2:129-41. [DOI: 10.1007/s40495-016-0056-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
10 Kumar C, Shetake N, Desai S, Kumar A, Samuel G, Pandey BN. Relevance of radiobiological concepts in radionuclide therapy of cancer. Int J Radiat Biol 2016;92:173-86. [PMID: 26917443 DOI: 10.3109/09553002.2016.1144944] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
11 Trevaskis NL, Kaminskas LM, Porter CJH. From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity. Nat Rev Drug Discov 2015;14:781-803. [DOI: 10.1038/nrd4608] [Cited by in Crossref: 370] [Cited by in F6Publishing: 378] [Article Influence: 46.3] [Reference Citation Analysis]
12 De Souza R, Spence T, Huang H, Allen C. Preclinical imaging and translational animal models of cancer for accelerated clinical implementation of nanotechnologies and macromolecular agents. J Control Release 2015;219:313-30. [PMID: 26409122 DOI: 10.1016/j.jconrel.2015.09.041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
13 Miller-Kleinhenz JM, Bozeman EN, Yang L. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2015;7:797-816. [PMID: 25966677 DOI: 10.1002/wnan.1343] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
14 Chen KJ, Chaung EY, Wey SP, Lin KJ, Cheng F, Lin CC, Liu HL, Tseng HW, Liu CP, Wei MC, Liu CM, Sung HW. Hyperthermia-mediated local drug delivery by a bubble-generating liposomal system for tumor-specific chemotherapy. ACS Nano 2014;8:5105-15. [PMID: 24742221 DOI: 10.1021/nn501162x] [Cited by in Crossref: 132] [Cited by in F6Publishing: 140] [Article Influence: 14.7] [Reference Citation Analysis]
15 Kraft JC, Freeling JP, Wang Z, Ho RJ. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J Pharm Sci 2014;103:29-52. [PMID: 24338748 DOI: 10.1002/jps.23773] [Cited by in Crossref: 336] [Cited by in F6Publishing: 348] [Article Influence: 33.6] [Reference Citation Analysis]